| 2.38 Data as of May 22 |  -0.02 / -0.83%Today’s Change | 1.99 Today|||52-Week Range 4.00 | +7.69% Year-to-Date |
| Previous close | 2.40 |
| Today’s open | 2.39 |
| Day’s range | -- - -- |
| Volume | 105,216 |
| Average volume (3 months) | 119,233 |
| Market cap | $91.3M |
| Dividend yield | -- |
| Earnings growth (last year) | -82.61% |
| Earnings growth (this year) | -20.81% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -28.71% |
| P/E ratio | NM |
| Price/Sales | 0.92 |
| Price/Book | 1.15 |
| Today’s change | Today’s % change | |
|---|---|---|
| PBMDPrima BioMed Ltd | +0.17 | +6.98% |
| BSTCBiospecifics Technol... | -0.17 | -1.08% |
| ENZEnzo Biochem Inc | -0.04 | -1.75% |
| STEMStemCells Inc | +0.01 | +0.54% |
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $88.3M |
| Annual profit (last year) | -$30.9M |
| Net profit margin | -34.95% |
Sector Process Industries |
Industry Chemicals: Specialty |
President, Chief Executive Officer & Director John J. Nicols, MBA |
Chief Financial Officer & Senior Vice President David D. O'Toole, CPA |
Corporate headquarters Redwood City, California |
.
